A Single-Center,Multiple dose, Randomized, Double-Blind, Double-Dummy, Placebo and Positive-Controlled, Study to Evaluate the Effect of Lixisenatide on the QTc Interval in Health Volunteers.
Latest Information Update: 18 Sep 2016
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 18 Sep 2016 New trial record